Announcements

  • November 19, 2014

    Today, the U.S. Department of Health and Human Services (HHS) issued a Notice of Proposed Rulemaking (NPRM), which proposes regulations to implement reporting requirements for clinical trials that are subject to Title VIII of the Food and Drug Administration Amendments Act of 2007 (FDAAA). The proposed rule clarifies requirements to clinical researchers for registering clinical trials and submitting summary trial results information to ClinicalTrials.gov, a publicly accessible database operated by the National Library of Medicine, part of the National Institutes of Health. A major change from current requirements that is proposed in the NPRM is the expansion of the scope of clinical trials required to submit summary results to include trials of unapproved, unlicensed, and uncleared products.

    In addition, NIH proposed a policy to promote transparency for all NIH-funded clinical trials, whether or not they are subject to FDAAA. The proposed policy expects registration and submission of results information like that required by FDAAA in ClinicalTrials.gov of every clinical trial that receives NIH dollars.

    Read the news release along with the NPRM and NIH proposed policy changes. HHS and NIH encourage public feedback during the 90-day comment period.

  • November 17, 2014

    Cartoon of four people in conversation.

    Like many other Institutes at NIH, NIA assesses and updates its research directions every few years. This exercise is an important one, resulting in a Strategic Directions document that helps set and communicate priorities for the Institute and for aging research. NIA is updating its Strategic Directions. Dr. Richard J. Hodes, NIA director, has a new blog post explaining how we use the Strategic Directions document and inviting participation. “We need to hear your voices to allow us to prepare a document that truly does reflect an ambitious and fitting agenda for the times ahead,” Dr. Hodes writes.

    Read the full blog post: Strategic Directions for Research on Aging

    The NIA blog publishes weekly with information on grants and funding policy, research priorities, scientific meetings, and topics of interest to researchers and others in the scientific community. Subscribe to get it weekly in your email inbox, or grab the RSS feed.

  • November 10, 2014

    Subject: Dr. Joanne Murabito, December 4 at the GeroScience Interest Group (GSIG) fall seminar (Open to the Public)

    When: Thursday, December 4, 2014, 12:00 PM – 1:00 PM

    Where: Lipsett Amphitheater, Building 10, NIH

    Title: “Genetics of Aging Phenotypes over the Life Course: A Population Perspective”

    “Open to the Public (please allow time for the NIH security check)”

    The Trans-NIH GeroScience Interest Group (GSIG) cordially invites you to its fall seminar, featuring Dr. Joanne Murabito. Dr. Murabito is Director of the Clinic at the Framingham Heart Study, and she is an Associate Professor of Medicine at Boston University School of Medicine. Dr. Murabito’s research goals have focused on aging and reproductive traits in the Framingham Heart study and beyond. Specifically, her research program focuses on using the tools of epidemiology and high-throughput genetic platforms to better understand the natural history of aging and to detect novel pathways and mechanisms for aging-related traits. Studies in her laboratory encompass analysis of genome-wide association studies of aging phenotypes in human population samples using common and rare variant platforms; and investigation of determinants of healthy aging in the Framingham population. Dr. Murabito’s current projects include the epidemiology of centenarian experience in Framingham, physical activity and function, and biomarkers of frailty. She leads several international consortia dedicated to uncovering genes for aging-related traits, including age at menarche, age at natural menopause, and longevity. She collaborates with scientists at the Jackson Laboratory Nathan Shock Center of Excellence in the Basic Biology of Aging to further identify the functional relevance of human association findings. Dr. Murabito is keenly interested in how to reach older participants through novel technologies and use those technologies to maintain health. Dr. Murabito’s research has demonstrated that multiple genetic loci underlie reproductive aging, which are associated with many downstream aging-related disorders including obesity, DNA damage and repair and immune function.

    The GeroScience Interest Group (GSIG) was formed to enhance opportunities for discussion of the intersection between the biology of aging and the biology of disease and conditions that are of interest across ICs. It is focused on basic biology, but with a longer view towards translation. If you are interested in learning more, please visit the GSIG web site.

    The seminar will be videocast at http://videocast.nih.gov and archived in the GSIG web site.

    Sign Language Interpreters will be provided. Individuals with disabilities who need reasonable accommodation to participate in this event should contact Dr. Young Oh at yoh@nhlbi.nih.gov or at 301/435-0560 or Dr. Ronald Kohanski at kohanskir@mail.nih.gov or at 301/496-6402.

    Please send your questions related to the seminar to yoh@nhlbi.nih.gov or kohanskir@mail.nih.gov.

  • November 5, 2014

    Cartoon of four people in conversation.

    Researchers writing grants or giving presentations strive to speak and write clearly about their science. However, many researchers struggle to find those simple words. “Plain language” is a common term for communication that your audience can easily understand and use the first time they hear or read it. This week, Vicky Cahan, Director of the NIA Office of Communications and Public Liaison, shares tips for avoiding common mistakes, and an example of how we worked with a scientist to rewrite scientific text for clearer communication.

    Read the full blog post: Explaining your science—tips for clear communication

    The NIA blog publishes weekly with information on grants and funding policy, research priorities, scientific meetings, and topics of interest to researchers and others in the scientific community. Subscribe to get it weekly in your email inbox, or grab the RSS feed.

  • November 7, 2014

    The November 2014 issue of NIA’s Spotlight on Aging Research e-newsletter is now available!

    In this issue:

    • Get an update about the NIA research budget and coming events from NIA Director Dr. Richard Hodes.
    • Read about past, present, and future research into falls, frailty, exceptional longevity, and more in a conversation with NIA’s director of geriatrics and clinical gerontology.
    • Watch a video of early- and mid-career researchers reflecting on the 2014 Butler-Williams Scholars Program.
    • Find out what’s new with Go4Life®, NIA’s exercise and physical activity campaign for older adults.
    • Learn about brain donation among African Americans and strategies for encouraging participation in Alzheimer’s research.
    • Read about the challenges experienced by dementia caregivers and a national panel’s ideas to better support caregivers.
    • Browse NIA research news, including funding opportunities, study findings, and recent NIA grant awards.

    Looking for more news from NIA?

  • November 4, 2014

    The Fall 2014 issue of Connections, the e-newsletter from NIA’s Alzheimer’s Disease Education and Referral (ADEAR) Center, is now available!

    In the latest issue:

    • Learn about brain donation by African Americans and how researchers build relationships and trust to encourage this group’s participation in medical studies.
    • Read about the challenges of dementia caregivers and a national Alzheimer’s panel’s ideas to better support them.
    • Find out about resources NIA offers to help primary care physicians screen for cognitive impairment, including a new tip sheet.
    • Check out the latest NIA-funded research findings related to Alzheimer’s.
    • Browse a list of clinical trials now recruiting.

    Want to get future issues of Connections and other Alzheimer’s and aging research news by e-mail? Sign up today! And follow us on Twitter @Alzheimers_NIH.

  • November 6, 2014

    Investigators interested in research on health disparities have a new mechanism to support their work: administrative supplements to existing NIA awards. These add-ons provide funds to start or expand health disparities-related aspects of the current grant not specified in the original grant proposal. They can support pilot research projects that connect to the parent NIA award, and emerging investigators can receive mentoring from the principal investigator of the parent award.

    For more information, see the blog post by Dr. Carl Hill on this topic.

  • November 3, 2014

    Cartoon of four people in conversation.

    What steps do we take next to accelerate the discovery and development of effective treatments for people at all stages of Alzheimer’s disease? That is the focus of the Alzheimer’s Disease Research Summit 2015: Path to Treatment and Prevention taking place February 9-10, 2015 at the NIH campus in Bethesda, Maryland.  Dr. Neil Buckholtz, Director of the NIA Division of Neuroscience, invites you to join this conversation by registering for this international conference convened by the NIA and the U.S. Department of Health and Human Services, with private support through the Foundation for the NIH.

    Read the full blog post: A meeting of the minds at the Alzheimer’s Disease Summit 2015

    The NIA blog publishes weekly with information on grants and funding policy, research priorities, scientific meetings, and topics of interest to researchers and others in the scientific community. Subscribe to get it weekly in your email inbox, or grab the RSS feed.

  • November 6, 2014

    Nine NIA staff recently received NIH Director’s Awards from NIH Director Dr. Francis S. Collins. Individuals were recognized for their superior performance and endeavors demonstrating efforts that go beyond regular duty requirements, but are directly related to fulfilling NIH’s mission.

    Awards presented at a June 12, 2014, ceremony included:

    • Geroscience Summit Organizing Committee Group Award—For dedication and commitment in promoting geroscience, specifically in organizing the multidisciplinary scientific summit Advances in Geroscience: Impact on Healthspan and Chronic Disease.

      Recipients: Drs. Evan Hadley, Ronald Kohanski, Felipe Sierra, and Bradley Wise
    • Division of Behavioral and Social Research Award—For exemplary leadership and innovation in the behavioral and social sciences to improve health and well-being in the U.S. and around the globe.

      Recipient: Dr. Richard Suzman

    Additional awards were presented to NIA staff for work on trans-NIH activities:

    • Alzheimer’s Disease-Related Dementias Planning Initiative Team Award—Nominated by National Institute of Neurological Disorders and Stroke, NIH

      Recipients: Drs. Creighton Phelps and Nina Silverberg
       
    • Trans-NIH American Indian/Alaska Native Health Communications and Information Work Group Award—Nominated by National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH

      Recipients: Vicky Cahan and Megan Homer
  • November 6, 2014

    Dr. Samir Sauma was named director of NIA’s Office of Planning, Analysis, and Evaluation (OPAE) following the retirement of Kathie Reed in July 2014. He previously served as deputy director of the office.

    As deputy director, Dr. Sauma was largely responsible for directing the analysis of NIA’s research portfolio; evaluating biomedical research programs and projects; coordinating and updating the NIA Strategic Directions document; serving as NIA’s main point of contact for the Research, Condition, and Disease Categorization database; and preparing NIA’s input to the annual report to Congress on trans-NIH collaborative research activities, and more.

    Before joining NIA in 2011, Dr. Sauma was senior health science analyst in the National Cancer Institute’s (NCI) Office of Science Planning. He holds a doctorate in pharmacology and molecular sciences from The Johns Hopkins University, along with a master’s degree in physical chemistry from Yale University and a master’s of public health from Harvard University.

    Kate Nagy was named to the post of OPAE deputy director. She previously was senior public health analyst in OPAE, where she coordinated and managed NIA scientific reporting activities and represented NIA on numerous NIH committees and working groups.

    Ms. Nagy was previously a program analyst in NCI’s Office of Science Planning and Assessment. She earned a B.A. in English from the University of Kansas and an M.A. in English from the University of Vermont.

Pages